T 2431/17 (Pharmaceutical Compositions having Desirable Bioavailability / ALCON) of 03.11.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T243117.20201103
- Date of decision
- 3 November 2020
- Case number
- T 2431/17
- Petition for review of
- -
- Application number
- 09722278.0
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY
- Applicant name
- Alcon Research, Ltd.
- Opponent name
- Pohlman, Sandra M.
Alfred E. Tiefenbacher (GmbH & Co. KG)
Generics [UK] Limited (trading as Mylan) - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2) (2007)European Patent Convention Art 54(3) (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 87(1) (2007)European Patent Convention R 80 (2007)Rules of procedure of the Boards of Appeal Art 11 (2020)
- Keywords
- Amendments - added subject-matter (no)
Sufficiency of disclosure - (yes)
Priority - transfer of priority right
Priority - validity of priority date (no)
Remittal - special reasons for remittal - Catchword
- -
Order
For these reasons it is decided that:
1. The decision is set aside.
2. The case is remitted to the opposition division for further prosecution.